Symbols / TAK Stock $16.70 +0.36% Takeda Pharmaceutical Company Limited

Healthcare • Drug Manufacturers - Specialty & Generic • Japan • NYQ
TAK (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Christophe P. Weber
Exch · Country NYQ · Japan
Market Cap 52.77B
Enterprise Value 4.79T
Income 112.93B
Sales 4.46T
FCF (ttm) 536.71B
Book/sh 15.16
Cash/sh 414.62
Employees 47,455
Insider 10d —
IPO Jan 05, 2010
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 80.03%
P/E 43.95
Forward P/E 31.51
PEG 0.33
P/S 0.01
P/B 1.10
P/C —
EV/EBITDA 3.76
EV/Sales 1.07
Quick Ratio 0.54
Current Ratio 1.19
Debt/Eq 70.93
LT Debt/Eq —
EPS (ttm) 0.38
EPS next Y 0.53
EPS Growth 3.30%
Revenue Growth 4.20%
EPS Gr Q/Q 3.36%
Rev Gr Q/Q —
Earnings (next) 2026-07-30
Earnings (prior) 2023-07-27
ROA 2.47%
ROE 1.50%
ROIC —
Gross Margin 65.53%
Oper. Margin 10.85%
Profit Margin 2.53%
Shs Outstand 3.16B
Shs Float 1.58B
Insider Own 0.02%
Instit Own 2.75%
Short Float 0.16%
Short Ratio 1.68
Short Interest 5.00M
52W High 18.90
vs 52W High -11.64%
52W Low 12.99
vs 52W Low 28.56%
Beta 0.10
Impl. Vol. 1.31%
Rel Volume 0.21
Avg Volume 2.90M
Volume 615.25K
Target (mean) $20.59
Tgt Median $21.03
Tgt Low $18.84
Tgt High $21.89
# Analysts 3
Recom Strong_buy
Prev Close $16.64
Price $16.70
Change 0.36%
About

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba Fiber, Recombinate, Hemofil, Immunate, Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-licensing agreements with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaborations with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Institute, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, and Teva Pharmaceutical Industries; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei, Zedira/Dr. Falk Pharma, Exelixi GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, KM Biologics, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics. The company was founded in 1781 and is headquartered in Tokyo, Japan.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$20.58
Mean price target
2. Current target
$16.70
Latest analyst target
3. DCF / Fair value
$3057.53
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$16.70
Low
$18.83
High
$21.89
Mean
$20.58

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-05-16 main TD Cowen Outperform → Outperform $20
2023-04-04 main TD Cowen — → Outperform $30
2023-03-16 up B of A Securities Neutral → Buy $20
2022-07-19 up Cowen & Co. Market Perform → Outperform $24
2021-10-07 down Morgan Stanley Overweight → Equal-Weight —
2020-03-11 main JP Morgan — → Overweight $30
2019-11-01 init Cowen & Co. — → Market Perform $20
2019-09-24 init Jefferies — → Buy —
News
RSS: Latest TAK news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-27 PLUMP ANDREW S. Officer and Director — 212,470 $0.00 $0
2026-04-27 BITETTI TERESA MARIE Officer — 64,988 $0.00 $0
2026-04-27 RICCI GABRIELE Chief Technology Officer — 34,994 $0.00 $0
2026-04-27 PLATFORD GILES RICHARD Officer — 72,124 $0.00 $0
2026-04-27 DUPREY LAUREN RUSCKOWSKI Officer — 59,990 $0.00 $0
2026-04-27 AGOSTI MARCELLO PIGNAGNOLI Officer — 27,740 $0.00 $0
2026-04-27 WEBER CHRISTOPHE PIERRE Chief Executive Officer — 165,370 $0.00 $0
2026-04-27 KIM JULIE SO-YOUNG Officer — 105,416 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
4,581,551.00
+7.45%
4,263,762.00
+5.87%
4,027,478.00
+12.85%
3,569,006.00
Operating Revenue
4,581,551.00
+7.45%
4,263,762.00
+5.87%
4,027,478.00
+12.85%
3,569,006.00
Cost Of Revenue
1,580,217.00
+10.76%
1,426,678.00
+14.68%
1,244,072.00
+12.40%
1,106,846.00
Reconciled Cost Of Revenue
1,462,054.00
+8.24%
1,350,793.00
+20.38%
1,122,115.00
+12.59%
996,610.00
Gross Profit
3,001,334.00
+5.79%
2,837,084.00
+1.93%
2,783,406.00
+13.05%
2,462,160.00
Operating Expense
2,515,273.00
+1.80%
2,470,919.00
+12.54%
2,195,594.00
+14.59%
1,916,117.00
Research And Development
730,227.00
+0.04%
729,924.00
+15.25%
633,325.00
+20.38%
526,087.00
Selling General And Administration
1,104,766.00
+4.83%
1,053,819.00
+5.67%
997,309.00
+12.52%
886,361.00
Other Operating Expenses
37,047.00
+5.67%
35,059.00
+55.70%
22,517.00
-26.78%
30,754.00
Total Expenses
4,095,490.00
+5.08%
3,897,597.00
+13.31%
3,439,666.00
+13.78%
3,022,963.00
Operating Income
486,061.00
+32.74%
366,165.00
-37.71%
587,812.00
+7.65%
546,043.00
Total Operating Income As Reported
342,586.00
+60.03%
214,075.00
-56.36%
490,505.00
+6.44%
460,844.00
EBITDA
1,073,791.00
+19.27%
900,328.00
-22.15%
1,156,463.00
+14.71%
1,008,154.00
Normalized EBITDA
1,239,111.00
+14.76%
1,079,710.00
-14.28%
1,259,585.00
+12.34%
1,121,266.00
Reconciled Depreciation
761,396.00
+4.59%
728,002.00
+9.57%
664,400.00
+13.93%
583,151.00
EBIT
312,395.00
+81.28%
172,326.00
-64.98%
492,063.00
+15.78%
425,003.00
Total Unusual Items
-165,320.00
+7.84%
-179,382.00
-73.95%
-103,122.00
+8.83%
-113,112.00
Total Unusual Items Excluding Goodwill
-165,320.00
+7.84%
-179,382.00
-73.95%
-103,122.00
+8.83%
-113,112.00
Special Income Charges
-172,923.00
-1.57%
-170,249.00
-55.39%
-109,562.00
-23.24%
-88,898.00
Other Special Charges
37,569.00
-40.72%
63,372.00
+157.52%
24,609.00
+565.47%
3,698.00
Restructuring And Mergern Acquisition
127,531.00
+24.89%
102,115.00
+61.51%
63,225.00
-12.96%
72,641.00
Write Off
18,384.00
+44.34%
12,737.00
-58.42%
30,629.00
+47.80%
20,723.00
Net Income
107,928.00
-25.08%
144,067.00
-54.56%
317,017.00
+37.80%
230,059.00
Pretax Income
175,084.00
+231.66%
52,791.00
-85.93%
375,090.00
+23.97%
302,571.00
Net Non Operating Interest Income Expense
-141,669.00
-0.86%
-140,463.00
-13.84%
-123,385.00
+0.07%
-123,477.00
Interest Expense Non Operating
137,311.00
+14.87%
119,535.00
+2.19%
116,973.00
-4.46%
122,432.00
Net Interest Income
—
—
-123,385.00
+0.07%
-123,477.00
Interest Expense
137,311.00
+14.87%
119,535.00
+2.19%
116,973.00
-4.46%
122,432.00
Interest Income Non Operating
19,638.00
+73.90%
11,293.00
+105.03%
5,508.00
+19.97%
4,591.00
Interest Income
19,638.00
+73.90%
11,293.00
+105.03%
5,508.00
+19.97%
4,591.00
Other Income Expense
-169,306.00
+2.08%
-172,909.00
-93.55%
-89,336.00
+25.55%
-119,997.00
Gain On Sale Of Security
7,603.00
+183.25%
-9,133.00
-241.82%
6,440.00
+126.60%
-24,214.00
Gain On Sale Of Business
10,198.00
+30.23%
7,831.00
+15.04%
6,807.00
-2.98%
7,016.00
Tax Provision
66,941.00
+173.23%
-91,406.00
-257.46%
58,052.00
-19.82%
72,405.00
Tax Rate For Calcs
0.00
+64.80%
0.00
+49.90%
0.00
-35.32%
0.00
Tax Effect Of Unusual Items
-63,207.87
-51.88%
-41,616.62
-160.76%
-15,960.01
+41.04%
-27,067.61
Net Income Including Noncontrolling Interests
108,143.00
-25.00%
144,197.00
-54.52%
317,038.00
+37.74%
230,166.00
Net Income From Continuing Operation Net Minority Interest
107,928.00
-25.08%
144,067.00
-54.56%
317,017.00
+37.80%
230,059.00
Net Income From Continuing And Discontinued Operation
107,928.00
-25.08%
144,067.00
-54.56%
317,017.00
+37.80%
230,059.00
Net Income Continuous Operations
108,143.00
-25.00%
144,197.00
-54.52%
317,038.00
+37.74%
230,166.00
Minority Interests
-215.00
-65.38%
-130.00
-519.05%
-21.00
+80.37%
-107.00
Normalized Income
210,040.13
-25.47%
281,832.38
-30.27%
404,178.99
+27.86%
316,103.39
Net Income Common Stockholders
107,928.00
-25.08%
144,067.00
-54.56%
317,017.00
+37.80%
230,059.00
Diluted EPS
33.62
-26.25%
45.58
-54.86%
100.97
+38.44%
72.94
Basic EPS
34.18
-25.77%
46.05
-54.92%
102.14
+38.84%
73.57
Basic Average Shares
3,157.75
+0.92%
3,128.90
+0.81%
3,103.62
-0.75%
3,127.00
Diluted Average Shares
3,210.65
+1.58%
3,160.69
+0.67%
3,139.74
-0.46%
3,154.34
Diluted NI Availto Com Stockholders
107,928.00
-25.08%
144,067.00
-54.56%
317,017.00
+37.80%
230,059.00
Amortization
643,233.00
-1.36%
652,117.00
+20.22%
542,443.00
+14.70%
472,915.00
Amortization Of Intangibles Income Statement
643,233.00
-1.36%
652,117.00
+20.22%
542,443.00
+14.70%
472,915.00
Depreciation Amortization Depletion Income Statement
643,233.00
-1.36%
652,117.00
+20.22%
542,443.00
+14.70%
472,915.00
Depreciation And Amortization In Income Statement
643,233.00
-1.36%
652,117.00
+20.22%
542,443.00
+14.70%
472,915.00
Earnings From Equity Interest
-3,986.00
-161.58%
6,473.00
-53.05%
13,786.00
+300.23%
-6,885.00
Gain On Sale Of PPE
363.00
+152.08%
144.00
-93.12%
2,094.00
+82.40%
1,148.00
Total Other Finance Cost
23,996.00
-25.53%
32,221.00
+170.31%
11,920.00
+111.50%
5,636.00
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Assets
14,248,344.00
-5.70%
15,108,792.00
+8.25%
13,957,750.00
+5.92%
13,178,018.00
Current Assets
2,521,192.00
-1.46%
2,558,580.00
+6.70%
2,397,956.00
-7.54%
2,593,642.00
Cash Cash Equivalents And Short Term Investments
405,589.00
-14.23%
472,889.00
-14.60%
553,704.00
-36.72%
875,000.00
Cash And Cash Equivalents
385,113.00
-15.88%
457,800.00
-14.19%
533,530.00
-37.21%
849,695.00
Cash Equivalents
151,371.00
-40.08%
252,611.00
-16.90%
303,973.00
-34.01%
460,637.00
Cash Financial
233,742.00
+13.91%
205,190.00
-10.61%
229,557.00
-41.00%
389,059.00
Other Short Term Investments
20,476.00
+35.70%
15,089.00
-25.21%
20,174.00
-20.28%
25,305.00
Receivables
725,254.00
+3.96%
697,610.00
+2.33%
681,694.00
-5.89%
724,378.00
Accounts Receivable
770,896.00
+7.27%
718,675.00
+6.52%
674,691.00
-5.01%
710,304.00
Receivables Adjustments Allowances
-119,481.00
-12.47%
-106,236.00
-7.03%
-99,260.00
-6.98%
-92,786.00
Other Receivables
58,050.00
+3.73%
55,964.00
-24.37%
73,999.00
-6.48%
79,127.00
Taxes Receivable
15,789.00
-45.94%
29,207.00
-9.47%
32,264.00
+16.34%
27,733.00
Inventory
1,217,349.00
+0.62%
1,209,869.00
+22.65%
986,457.00
+15.62%
853,167.00
Raw Materials
341,636.00
+1.19%
337,612.00
+20.19%
280,908.00
+24.86%
224,977.00
Work In Process
552,200.00
+5.65%
522,667.00
+19.74%
436,508.00
+8.02%
404,087.00
Finished Goods
323,513.00
-7.46%
349,590.00
+29.94%
269,042.00
+20.05%
224,102.00
Assets Held For Sale Current
13,397.00
+43.48%
9,337.00
-38.71%
15,235.00
0.00
Other Current Assets
159,603.00
-5.49%
168,875.00
+4.98%
160,866.00
+14.01%
141,097.00
Total Non Current Assets
11,727,152.00
-6.56%
12,550,214.00
+8.57%
11,559,794.00
+9.22%
10,584,377.00
Net PPE
1,968,209.00
-1.08%
1,989,777.00
+17.65%
1,691,229.00
+6.85%
1,582,800.00
Gross PPE
3,273,239.00
+1.95%
3,210,478.00
+18.95%
2,698,983.00
+10.03%
2,453,008.00
Accumulated Depreciation
-1,305,030.00
-6.91%
-1,220,701.00
-21.13%
-1,007,754.00
-15.81%
-870,208.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
104,342.00
-1.42%
105,845.00
+7.76%
98,227.00
-0.43%
98,654.00
Buildings And Improvements
1,671,876.00
-0.43%
1,679,054.00
+19.92%
1,400,108.00
+8.66%
1,288,578.00
Machinery Furniture Equipment
1,175,365.00
+2.48%
1,146,889.00
+15.47%
993,249.00
+9.40%
907,919.00
Construction In Progress
321,656.00
+15.42%
278,689.00
+34.37%
207,400.00
+31.39%
157,856.00
Goodwill And Other Intangible Assets
8,955,990.00
-7.52%
9,684,750.00
+6.89%
9,060,380.00
+10.14%
8,226,294.00
Goodwill
5,324,430.00
-1.58%
5,410,067.00
+12.93%
4,790,723.00
+8.69%
4,407,749.00
Other Intangible Assets
3,631,560.00
-15.04%
4,274,683.00
+0.12%
4,269,657.00
+11.81%
3,818,545.00
Investments And Advances
361,926.00
-15.95%
430,608.00
+13.66%
378,857.00
+14.76%
330,133.00
Long Term Equity Investment
10,802.00
-87.98%
89,831.00
-9.42%
99,174.00
+2.69%
96,579.00
Non Current Deferred Assets
370,745.00
-5.87%
393,865.00
+7.61%
366,003.00
+0.96%
362,539.00
Non Current Deferred Taxes Assets
370,745.00
-5.87%
393,865.00
+7.61%
366,003.00
+0.96%
362,539.00
Other Non Current Assets
70,282.00
+37.23%
51,214.00
-19.13%
63,325.00
-23.35%
82,611.00
Total Liabilities Net Minority Interest
7,312,365.00
-6.67%
7,834,787.00
+3.05%
7,603,079.00
+1.45%
7,494,495.00
Current Liabilities
2,506,521.00
+8.36%
2,313,103.00
-6.80%
2,481,940.00
+15.67%
2,145,730.00
Payables And Accrued Expenses
609,038.00
-7.36%
657,427.00
-25.43%
881,610.00
+22.92%
717,216.00
Payables
609,038.00
-7.36%
657,427.00
-25.43%
881,610.00
+22.92%
717,216.00
Accounts Payable
308,450.00
-3.60%
319,955.00
+4.07%
307,453.00
+3.89%
295,934.00
Other Payable
167,091.00
-26.57%
227,566.00
-33.42%
341,780.00
+55.10%
220,364.00
Employee Benefits
135,429.00
-5.87%
143,882.00
+12.77%
127,594.00
-12.52%
145,847.00
Total Tax Payable
133,497.00
+21.46%
109,906.00
-52.70%
232,377.00
+15.66%
200,918.00
Income Tax Payable
133,497.00
+21.46%
109,906.00
-52.70%
232,377.00
+15.66%
200,918.00
Current Debt And Capital Lease Obligation
548,939.00
+49.47%
367,251.00
+8.14%
339,600.00
+66.48%
203,993.00
Current Debt
548,939.00
+49.47%
367,251.00
+8.14%
339,600.00
+66.48%
203,993.00
Other Current Borrowings
548,939.00
+49.47%
367,251.00
+8.14%
339,600.00
+66.48%
203,993.00
Other Current Liabilities
815,404.00
+6.73%
764,005.00
+1.55%
752,370.00
-3.67%
781,019.00
Total Non Current Liabilities Net Minority Interest
4,805,844.00
-12.96%
5,521,684.00
+7.82%
5,121,139.00
-4.26%
5,348,765.00
Long Term Debt And Capital Lease Obligation
3,966,326.00
-11.40%
4,476,501.00
+10.73%
4,042,741.00
-2.38%
4,141,418.00
Long Term Debt
3,966,326.00
-11.40%
4,476,501.00
+10.73%
4,042,741.00
-2.38%
4,141,418.00
Long Term Provisions
35,177.00
+144.74%
14,373.00
-74.32%
55,969.00
+7.22%
52,199.00
Non Current Pension And Other Postretirement Benefit Plans
135,429.00
-5.87%
143,882.00
+12.77%
127,594.00
-12.52%
145,847.00
Tradeand Other Payables Non Current
317.00
-92.76%
4,381.00
-82.16%
24,558.00
+13.52%
21,634.00
Non Current Deferred Liabilities
35,153.00
-69.10%
113,777.00
-57.96%
270,620.00
-40.06%
451,511.00
Non Current Deferred Taxes Liabilities
35,153.00
-69.10%
113,777.00
-57.96%
270,620.00
-40.06%
451,511.00
Other Non Current Liabilities
633,442.00
-17.60%
768,770.00
+28.20%
599,657.00
+11.84%
536,156.00
Stockholders Equity
6,935,084.00
-4.65%
7,273,264.00
+14.47%
6,354,122.00
+11.81%
5,683,019.00
Common Stock Equity
6,935,084.00
-4.65%
7,273,264.00
+14.47%
6,354,122.00
+11.81%
5,683,019.00
Capital Stock
1,694,685.00
+1.08%
1,676,596.00
+0.01%
1,676,345.00
+0.00%
1,676,263.00
Common Stock
1,694,685.00
+1.08%
1,676,596.00
+0.01%
1,676,345.00
+0.00%
1,676,263.00
Share Issued
1,590.95
+0.54%
1,582.42
+0.01%
1,582.30
+0.00%
1,582.25
Ordinary Shares Number
1,573.65
+0.30%
1,569.01
+0.93%
1,554.53
-0.33%
1,559.61
Treasury Shares Number
17.30
+29.05%
13.41
-51.72%
27.77
+22.61%
22.65
Additional Paid In Capital
1,775,713.00
+1.62%
1,747,414.00
+1.07%
1,728,830.00
+1.17%
1,708,873.00
Retained Earnings
1,187,586.00
-14.64%
1,391,203.00
-9.73%
1,541,146.00
+4.15%
1,479,716.00
Treasury Stock
74,815.00
+45.95%
51,259.00
-48.90%
100,317.00
-13.53%
116,007.00
Minority Interest
895.00
+20.78%
741.00
+34.97%
549.00
+8.93%
504.00
Total Equity Gross Minority Interest
6,935,979.00
-4.65%
7,274,005.00
+14.47%
6,354,671.00
+11.81%
5,683,523.00
Total Capitalization
10,901,410.00
-7.22%
11,749,765.00
+13.01%
10,396,863.00
+5.83%
9,824,437.00
Working Capital
14,671.00
-94.02%
245,477.00
+392.29%
-83,984.00
-118.75%
447,912.00
Invested Capital
11,450,349.00
-5.50%
12,117,016.00
+12.86%
10,736,463.00
+7.06%
10,028,430.00
Total Debt
4,515,265.00
-6.78%
4,843,752.00
+10.53%
4,382,341.00
+0.85%
4,345,411.00
Net Debt
4,130,152.00
-5.83%
4,385,952.00
+13.96%
3,848,811.00
+10.10%
3,495,716.00
Net Tangible Assets
-2,020,906.00
+16.20%
-2,411,486.00
+10.89%
-2,706,258.00
-6.41%
-2,543,275.00
Tangible Book Value
-2,020,906.00
+16.20%
-2,411,486.00
+10.89%
-2,706,258.00
-6.41%
-2,543,275.00
Available For Sale Securities
351,124.00
+3.04%
340,777.00
+21.84%
279,683.00
+19.75%
233,554.00
Current Provisions
533,140.00
+1.66%
524,420.00
+3.16%
508,360.00
+14.62%
443,502.00
Investmentin Financial Assets
351,124.00
+3.04%
340,777.00
+21.84%
279,683.00
+19.75%
233,554.00
Other Equity Interest
2,351,915.00
-6.27%
2,509,310.00
+66.39%
1,508,118.00
+61.44%
934,174.00
Other Inventories
—
—
-1.00
-200.00%
1.00
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
1,057,182.00
+47.58%
716,344.00
-26.69%
977,156.00
-13.00%
1,123,105.00
Cash Flow From Continuing Operating Activities
1,057,181.00
+47.58%
716,344.00
-26.69%
977,157.00
-13.00%
1,123,107.00
Net Income From Continuing Operations
108,143.00
-25.00%
144,197.00
-54.52%
317,038.00
+37.74%
230,166.00
Depreciation Amortization Depletion
761,396.00
+4.59%
728,002.00
+9.57%
664,400.00
+13.93%
583,151.00
Depreciation And Amortization
761,396.00
+4.59%
728,002.00
+9.57%
664,400.00
+13.93%
583,151.00
Other Non Cash Items
153,410.00
-4.24%
160,201.00
+789.71%
18,006.00
-90.23%
184,314.00
Stock Based Compensation
72,867.00
+2.82%
70,871.00
+16.81%
60,672.00
+39.88%
43,374.00
Asset Impairment Charge
106,529.00
-28.99%
150,017.00
+132.97%
64,394.00
+18.12%
54,515.00
Deferred Tax
66,941.00
+173.23%
-91,406.00
-257.46%
58,052.00
-19.82%
72,405.00
Deferred Income Tax
66,941.00
+173.23%
-91,406.00
-257.46%
58,052.00
-19.82%
72,405.00
Operating Gains Losses
-1,717.00
+79.20%
-8,253.00
-550.25%
1,833.00
-77.63%
8,193.00
Unrealized Gain Loss On Investment Securities
-602.00
-102.90%
20,757.00
+420.10%
3,991.00
+135.65%
-11,195.00
Gain Loss On Sale Of PPE
4,495.00
-25.73%
6,052.00
+60420.00%
10.00
-98.47%
655.00
Change In Working Capital
-59,372.00
+76.81%
-256,003.00
-913.31%
-25,264.00
-125.62%
98,605.00
Change In Receivables
-58,959.00
-490.35%
15,104.00
-79.90%
75,127.00
-40.98%
127,294.00
Change In Inventory
-34,973.00
+69.78%
-115,743.00
-46.22%
-79,155.00
-71.52%
-46,148.00
Change In Payables And Accrued Expense
-7,118.00
+28.06%
-9,895.00
+88.33%
-84,804.00
-167.76%
125,157.00
Change In Payable
-7,118.00
+28.06%
-9,895.00
+88.33%
-84,804.00
-167.76%
125,157.00
Change In Other Working Capital
45,166.00
+135.59%
-126,901.00
-497.82%
31,899.00
+154.91%
-58,090.00
Change In Other Current Liabilities
-3,488.00
+81.21%
-18,568.00
-158.63%
31,669.00
+163.84%
-49,608.00
Investing Cash Flow
-367,060.00
+20.87%
-463,862.00
+23.59%
-607,102.00
-206.42%
-198,125.00
Cash Flow From Continuing Investing Activities
-367,061.00
+20.87%
-463,861.00
+23.59%
-607,102.00
-206.42%
-198,126.00
Net PPE Purchase And Sale
-200,717.00
-20.32%
-166,814.00
-19.41%
-139,695.00
-15.03%
-121,437.00
Purchase Of PPE
-200,795.00
-14.47%
-175,420.00
-24.71%
-140,657.00
-14.12%
-123,252.00
Sale Of PPE
78.00
-99.09%
8,606.00
+794.59%
962.00
-47.00%
1,815.00
Capital Expenditure
-379,625.00
+21.03%
-480,730.00
+24.14%
-633,689.00
-240.63%
-186,037.00
Net Investment Purchase And Sale
-81,941.00
-155.71%
-32,045.00
-364.77%
12,103.00
+41.06%
8,580.00
Purchase Of Investment
-111,383.00
-178.00%
-40,066.00
-294.70%
-10,151.00
-21.70%
-8,341.00
Sale Of Investment
29,442.00
+267.06%
8,021.00
-63.96%
22,254.00
+31.52%
16,921.00
Net Business Purchase And Sale
77,243.00
+287.01%
19,959.00
+150.80%
7,958.00
+137.06%
-21,476.00
Purchase Of Business
-1,004.00
0.00
0.00
+100.00%
-49,672.00
Gain Loss On Sale Of Business
-10,198.00
-30.21%
-7,832.00
-15.06%
-6,807.00
+13.05%
-7,829.00
Net Intangibles Purchase And Sale
-178,830.00
+41.43%
-305,310.00
+38.08%
-493,032.00
-685.27%
-62,785.00
Purchase Of Intangibles
-178,830.00
+41.43%
-305,310.00
+38.08%
-493,032.00
-685.27%
-62,785.00
Net Other Investing Changes
-1,110.00
+72.28%
-4,004.00
-31.19%
-3,052.00
+58.35%
-7,327.00
Financing Cash Flow
-751,425.00
-112.02%
-354,416.00
+50.02%
-709,148.00
+33.74%
-1,070,265.00
Cash Flow From Continuing Financing Activities
-751,423.00
-112.02%
-354,415.00
+50.02%
-709,149.00
+33.74%
-1,070,265.00
Net Issuance Payments Of Debt
-314,314.00
-20874.22%
1,513.00
+100.53%
-285,071.00
+52.53%
-600,477.00
Issuance Of Debt
1,051,950.00
+179.03%
377,000.00
+227.83%
115,000.00
-53.88%
249,334.00
Repayment Of Debt
-1,366,264.00
-263.86%
-375,487.00
+6.14%
-400,071.00
+52.92%
-849,809.00
Long Term Debt Issuance
1,024,460.00
+924.46%
100,000.00
+33.33%
75,000.00
-69.92%
249,334.00
Long Term Debt Payments
-1,366,264.00
-263.86%
-375,487.00
+6.14%
-400,071.00
+52.92%
-849,809.00
Net Long Term Debt Issuance
-341,804.00
-24.07%
-275,487.00
+15.25%
-325,071.00
+45.86%
-600,475.00
Short Term Debt Issuance
27,490.00
-90.08%
277,000.00
+592.50%
40,000.00
—
Short Term Debt Payments
—
—
—
-2.00
Net Short Term Debt Issuance
27,490.00
-90.08%
277,000.00
+592.50%
40,000.00
+2000100.00%
-2.00
Net Common Stock Issuance
-51,860.00
-2129.58%
-2,326.00
+91.36%
-26,929.00
+65.27%
-77,531.00
Common Stock Payments
-51,860.00
-2129.58%
-2,326.00
+91.36%
-26,929.00
+65.27%
-77,531.00
Common Stock Dividend Paid
—
—
-279,416.00
+1.50%
-283,665.00
Cash Dividends Paid
-302,498.00
-5.33%
-287,188.00
-2.78%
-279,416.00
+1.50%
-283,665.00
Repurchase Of Capital Stock
-51,860.00
-2129.58%
-2,326.00
+91.36%
-26,929.00
+65.27%
-77,531.00
Net Other Financing Charges
30,231.00
-10.98%
33,960.00
+470.06%
-9,177.00
-2283.64%
-385.00
Changes In Cash
-61,302.00
+39.86%
-101,934.00
+69.94%
-339,094.00
-133.40%
-145,285.00
Effect Of Exchange Rate Changes
-11,385.00
-143.45%
26,204.00
+14.28%
22,929.00
-20.27%
28,758.00
Beginning Cash Position
457,800.00
-14.19%
533,530.00
-37.21%
849,695.00
-12.06%
966,222.00
End Cash Position
385,113.00
-15.88%
457,800.00
-14.19%
533,530.00
-37.21%
849,695.00
Free Cash Flow
677,557.00
+187.57%
235,614.00
-31.40%
343,467.00
-63.35%
937,068.00
Dividends Received CFI
635.00
-95.19%
13,191.00
+270.33%
3,562.00
+4.73%
3,401.00
Earnings Losses From Equity Investments
3,986.00
+161.58%
-6,473.00
-175.01%
8,630.00
-43.84%
15,367.00
Interest Paid CFF
-112,984.00
-12.56%
-100,375.00
+7.54%
-108,555.00
-0.32%
-108,207.00
Interest Received CFI
17,660.00
+58.23%
11,161.00
+120.83%
5,054.00
+73.14%
2,919.00
Sale Of Business
78,247.00
+292.04%
19,959.00
+150.80%
7,958.00
-71.78%
28,196.00
Taxes Refund Paid
-150,413.00
+25.55%
-202,039.00
-8.64%
-185,966.00
-32.43%
-140,423.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category